Please login to the form below

Not currently logged in
Email:
Password:

Aspen

This page shows the latest Aspen news and features for those working in and with pharma, biotech and healthcare.

BeiGene’s Brukinsa misses the mark in head-to-head Imbruvica trial

BeiGene’s Brukinsa misses the mark in head-to-head Imbruvica trial

In the ASPEN trial, Brukinsa hit higher rates of CR and VGPR compared to Imbruvica – 28.9% of relapsed or refractory patients compared to 19.8%.

Latest news

More from news
Approximately 9 fully matching, plus 21 partially matching documents found.

Latest Intelligence

  • Strengthening business competition and reducing anti-competitive practices Strengthening business competition and reducing anti-competitive practices

    based on the allegation that Aspen had paid these competitors to not enter the market. ... In a landmark move, and as the direct product of the investigation, Aspen approached the CMA with an unprecedented settlement offer.

  • A new EU in the making, what lies ahead for pharma? A new EU in the making, what lies ahead for pharma?

    She has been creative in the way she pushed the boundaries of the treaties with, for example, the pricing investigation over Aspen Pharma.

  • Deal Watch October 2016 Deal Watch October 2016

    $330m. Neurology 2016. Aspen. 5 anesthetics. $770m royalties. $592m. 1.3. Neurology 2014.

  • Deal Watch September 2016 Deal Watch September 2016

    Reflecting a long standing business relationship, Aspen paid GSK £180m to acquire Ultiva, Nimbex, Tracrium, Mivacron and Anectinein, plus up to £100m in milestone payments. ... 500. GSK / Aspen. Asset acquisition. Sale of anaesthetic drugs [Ultiva,

  • Deal Watch June 2016 Deal Watch June 2016

    Meanwhile AstraZeneca has out-licensed ex-US rights to a portfolio of seven anaesthetics to Aspen. ... Paying $520m upfront Aspen gains access to a series of local anaesthetics including Marcaine (bupivacaine) and Xylocaine (lidocaine/ lignocaine), and

More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest from PMHub

  • Competition from within

    Teva (Israel), CSL (Australia) and Aspen (South Africa) are notable exceptions, with the Indian generic giants Sun and Ranbaxy - which have since merged - the only representation from the ‘BRIC’ markets (Brazil,

  • Compliance Hub Ltd

    Address:. Aspen Farm. Sheep Lane Woburn. Bedfordshire. MK17 9HD. UK.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aurora Healthcare Communications

We're a leading healthcare strategic communications agency helping pharmaceutical companies adapt fast to improve the lives of patients and healthcare...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics